ArticleCancer science2026

SLAMF6 Enhances the Efficacy of Anti-PD-L1 Immunotherapy in CRC Through the STAT1/CXCL10 Signaling Axis.

Yu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.